Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study. [electronic resource]
Producer: 20160503Description: 548-52 p. digitalISSN:- 1756-185X
- Adalimumab -- pharmacology
- Adult
- Alanine Transaminase -- metabolism
- Antirheumatic Agents -- pharmacology
- Aspartate Aminotransferases -- metabolism
- Blood Sedimentation -- drug effects
- C-Reactive Protein -- metabolism
- Etanercept -- pharmacology
- Female
- Follow-Up Studies
- Humans
- Infliximab -- pharmacology
- Liver -- drug effects
- Liver Function Tests
- Longitudinal Studies
- Male
- Middle Aged
- Retrospective Studies
- Severity of Illness Index
- Spondylitis, Ankylosing -- drug therapy
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.